Related Experiment Video
Updated: Apr 14, 2026
The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration
Published on: November 26, 2015
Challenges in the management of acute mastoiditis in children
Sofia Kordeluk1, Mordechai Kraus, Eugene Leibovitz
1Department of Otorhinolaryngology, Soroka University Medical Center, Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva, Israel.
Abstract:
Acute mastoiditis (AM) is a rare but serious complication of otitis media. Recent studies consolidated the role of Streptococcus pyogenes as the second most important etiologic agent of AM and suggested an increased involvement of a relatively new pathogen (Fusobacterium necrophorum). The recently accumulated evidence on AM epidemiology in children is conflicting and not convincing in demonstrating clear trends during the last years. While a significant decrease was recorded in the incidence of pneumococcal invasive disease and complicated AOM following the introduction of the pneumococcal conjugate vaccines, data on the efficacy of these vaccines in the prevention of AM are limited and did not show any remarkable changes in the dynamics of disease caused by Streptococcus pneumoniae. The clinical findings in AM may differ according to the causative pathogen and different patient age subgroups. Together with computerized tomography, magnetic resonance imaging became frequently used, particularly in the diagnosis of AM complications. Simple mastoidectomy remains the most reliable and effective surgical intervention for the treatment of subperiosteal abscesses.
Insights
Acute mastoiditis (AM) is a serious complication of otitis media. Streptococcus pyogenes and Fusobacterium necrophorum are key pathogens, with limited impact of vaccines on Streptococcus pneumoniae-related AM.
Area of Science:
- Otolaryngology
- Pediatric Infectious Diseases
- Microbiology
Background:
- Acute mastoiditis (AM) is a rare but serious complication of otitis media.
- Streptococcus pyogenes is a significant cause of AM, with emerging evidence implicating Fusobacterium necrophorum.
- Current trends in AM epidemiology, particularly in children, remain unclear and conflicting.
Purpose of the Study:
- To review the current understanding of acute mastoiditis epidemiology.
- To analyze the role of specific pathogens in AM.
- To evaluate the impact of pneumococcal conjugate vaccines on AM incidence.
Main Methods:
- Literature review of recent studies on AM.
- Analysis of etiological agents and epidemiological trends.
- Assessment of diagnostic imaging techniques and surgical interventions.
Main Results:
- Streptococcus pyogenes is the second most common cause of AM.
- Fusobacterium necrophorum is an increasingly recognized pathogen in AM.
- Pneumococcal conjugate vaccines show limited impact on Streptococcus pneumoniae-related AM incidence.
Conclusions:
- AM etiology is evolving, with increasing roles for S. pyogenes and F. necrophorum.
- The efficacy of current vaccines in preventing AM requires further investigation.
- Advanced imaging and surgical interventions remain crucial for managing AM and its complications.
Related Concept Videos
01:26Tonsillitis II: Management
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
01:30Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
01:18Viral Meningitis
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Tonsillitis I: Introduction
Etiology
Three primary contributing factors have been identified.